VIROPHARMA INC Insider Trading for January 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VIROPHARMA INC for January 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 17.30 | 15,000 | 259,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 10.76 | 15,000 | 161,400 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 5.68 | 15,000 | 85,200 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 9.15 | 10,000 | 91,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 17.76 | 10,000 | 177,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 9.29 | 25,000 | 232,250 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | D | 9.29 | 7,500 | 69,675 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Sell | U | 50.00 | 9,000 | 450,000 | 0 | 9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | D | 17.30 | 15,000 | 259,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | D | 17.76 | 10,000 | 177,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | D | 20.15 | 10,000 | 201,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | U | 50.00 | 49,000 | 2,450,000 | 0 | 49 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | D | 27.99 | 12,500 | 349,875 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | D | 0.00 | 2,084 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Sell | U | 50.00 | 8,666 | 433,300 | 0 | 8.7 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 17.30 | 15,000 | 259,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 10.76 | 15,000 | 161,400 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 5.68 | 15,000 | 85,200 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 9.15 | 10,000 | 91,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 17.76 | 10,000 | 177,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 20.15 | 10,000 | 201,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | D | 20.43 | 25,000 | 510,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Leone John R | Director | Sell | U | 50.00 | 11,000 | 550,000 | 0 | 11 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 17.30 | 15,000 | 259,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 10.76 | 15,000 | 161,400 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 5.68 | 15,000 | 85,200 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 9.15 | 10,000 | 91,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | D | 17.76 | 10,000 | 177,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Sell | U | 50.00 | 45,860 | 2,293,000 | 0 | 45.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 17.30 | 15,000 | 259,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 10.76 | 15,000 | 161,400 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 5.68 | 15,000 | 85,200 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 9.15 | 10,000 | 91,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 17.76 | 10,000 | 177,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | D | 20.15 | 10,000 | 201,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Sell | U | 50.00 | 20,812 | 1,040,600 | 0 | 20.8 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 5.68 | 15,000 | 85,200 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 17.30 | 15,000 | 259,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 31.74 | 15,000 | 476,100 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 25.25 | 15,000 | 378,750 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 17.76 | 10,000 | 177,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 20.15 | 10,000 | 201,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 9.15 | 10,000 | 91,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 3.00 | 25,000 | 75,000 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | D | 10.76 | 15,000 | 161,400 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Sell | U | 50.00 | 128,314 | 6,415,700 | 0 | 128.3 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | D | 27.79 | 32,516 | 903,620 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | D | 23.37 | 34,570 | 807,901 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | D | 20.07 | 26,793 | 537,736 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | D | 28.16 | 27,265 | 767,782 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | D | 17.98 | 20,131 | 361,955 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | D | 17.84 | 18,059 | 322,173 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Sell | D | 0.00 | 48,878 | 0 | 0 | 48.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Grant | A | 0.00 | 48,878 | 0 | 48,878 | 0 to 48.9 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Sell | U | 50.00 | 110,768 | 5,538,400 | 0 | 110.8 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 27.79 | 43,355 | 1,204,835 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 23.37 | 46,093 | 1,077,193 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 20.07 | 48,334 | 970,063 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 28.16 | 36,890 | 1,038,822 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 17.98 | 54,470 | 979,371 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 17.84 | 54,470 | 971,745 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 11.31 | 62,500 | 706,875 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 8.86 | 30,304 | 268,493 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 13.50 | 67,593 | 912,506 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 9.99 | 74,975 | 749,000 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 9.96 | 14,999 | 149,390 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 13.97 | 40,000 | 558,800 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 15.24 | 33,439 | 509,610 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | D | 12.83 | 68,824 | 883,012 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Sell | D | 0.00 | 65,818 | 0 | 0 | 65.8 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Grant | A | 0.00 | 65,818 | 0 | 65,818 | 0 to 65.8 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Sell | U | 50.00 | 153,332 | 7,666,600 | 0 | 153.3 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 11.96 | 15,756 | 188,442 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 27.79 | 32,516 | 903,620 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 23.37 | 34,570 | 807,901 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 20.07 | 35,723 | 716,961 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 28.16 | 27,265 | 767,782 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 17.98 | 40,261 | 723,893 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 17.84 | 40,261 | 718,256 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 11.31 | 50,000 | 565,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 8.86 | 13,714 | 121,506 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | D | 13.50 | 52,593 | 710,006 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Sell | D | 0.00 | 48,878 | 0 | 0 | 48.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Grant | A | 0.00 | 48,878 | 0 | 48,878 | 0 to 48.9 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Sell | U | 50.00 | 87,026 | 4,351,300 | 0 | 87 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 20.07 | 35,723 | 716,961 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 27.79 | 32,516 | 903,620 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 23.37 | 34,570 | 807,901 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 28.16 | 27,265 | 767,782 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 17.98 | 40,261 | 723,893 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 17.84 | 40,261 | 718,256 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 11.31 | 50,000 | 565,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 8.86 | 13,714 | 121,506 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 13.50 | 52,593 | 710,006 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 9.99 | 9,975 | 99,650 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 9.96 | 8,295 | 82,618 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 13.97 | 14,000 | 195,580 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | D | 15.08 | 90,000 | 1,357,200 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | D | 0.00 | 48,878 | 0 | 0 | 48.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Grant | A | 0.00 | 48,878 | 0 | 48,878 | 0 to 48.9 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | U | 50.00 | 70,877 | 3,543,850 | 0 | 70.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 27.79 | 61,420 | 1,706,862 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 23.37 | 65,299 | 1,526,038 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 20.07 | 71,447 | 1,433,941 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 28.16 | 54,530 | 1,535,565 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 17.98 | 80,521 | 1,447,768 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 17.84 | 80,521 | 1,436,495 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 11.31 | 17,500 | 197,925 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 8.86 | 33,714 | 298,706 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | D | 19.73 | 54,932 | 1,083,808 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | D | 0.00 | 311,798 | 0 | 0 | 311.8 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Grant | A | 0.00 | 311,798 | 0 | 311,798 | 0 to 311.8 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | U | 50.00 | 482,281 | 24,114,050 | 0 | 482.3 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Option Exercise | D | 27.79 | 6,000 | 166,740 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Option Exercise | D | 23.37 | 3,960 | 92,545 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Option Exercise | D | 26.93 | 15,000 | 403,950 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Sell | D | 0.00 | 1,980 | 0 | 0 | 2 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Grant | A | 0.00 | 1,980 | 0 | 1,980 | 0 to 2 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Sell | U | 50.00 | 60 | 3,000 | 0 | 60 to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 11.31 | 5,343 | 60,429 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 27.79 | 32,516 | 903,620 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 23.37 | 34,570 | 807,901 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 20.07 | 35,723 | 716,961 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 28.16 | 27,265 | 767,782 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 17.98 | 26,261 | 472,173 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 17.84 | 20,863 | 372,196 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 8.86 | 9,000 | 79,740 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 5.91 | 4,000 | 23,640 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 13.50 | 6,000 | 81,000 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 13.97 | 3,000 | 41,910 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 15.24 | 4,380 | 66,751 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 8.71 | 4,265 | 37,148 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 19.73 | 9,578 | 188,974 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 19.73 | 1,222 | 24,110 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 7.05 | 12,000 | 84,600 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 3.14 | 18,000 | 56,520 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | D | 9.99 | 4,988 | 49,830 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Sell | D | 0.00 | 48,878 | 0 | 0 | 48.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Grant | A | 0.00 | 48,878 | 0 | 48,878 | 0 to 48.9 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Sell | U | 50.00 | 37,227 | 1,861,350 | 0 | 37.2 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 27.79 | 32,516 | 903,620 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 23.37 | 34,570 | 807,901 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 20.07 | 35,723 | 716,961 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 28.16 | 27,265 | 767,782 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 17.98 | 40,261 | 723,893 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 17.84 | 40,261 | 718,256 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 11.31 | 50,000 | 565,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 8.86 | 111,920 | 991,611 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 5.91 | 30,000 | 177,300 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 13.50 | 52,593 | 710,006 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 9.99 | 49,975 | 499,250 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 9.96 | 14,999 | 149,390 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 13.97 | 40,000 | 558,800 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 15.24 | 33,439 | 509,610 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 8.71 | 50,000 | 435,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 19.73 | 34,932 | 689,208 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | D | 7.05 | 32,497 | 229,104 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Sell | D | 0.00 | 48,878 | 0 | 0 | 48.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Grant | A | 0.00 | 48,878 | 0 | 48,878 | 0 to 48.9 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Sell | U | 50.00 | 112,089 | 5,604,450 | 0 | 112.1 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 13.97 | 40,000 | 558,800 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 27.79 | 32,516 | 903,620 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 23.37 | 34,570 | 807,901 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 20.07 | 35,723 | 716,961 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 28.16 | 27,265 | 767,782 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 17.98 | 40,261 | 723,893 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 17.84 | 40,261 | 718,256 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 11.31 | 50,000 | 565,500 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 8.86 | 36,920 | 327,111 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 13.50 | 52,593 | 710,006 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 9.99 | 49,975 | 499,250 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 15.24 | 33,439 | 509,610 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | D | 19.73 | 34,932 | 689,208 | 0 | |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | D | 0.00 | 48,878 | 0 | 0 | 48.9 K to 0 (-100.00 %) |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Grant | A | 0.00 | 48,878 | 0 | 48,878 | 0 to 48.9 K |
| Jan 28 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | U | 50.00 | 154,058 | 7,702,900 | 0 | 154.1 K to 0 (-100.00 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 8.86 | 13,080 | 115,889 | 111,920 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 5.91 | 10,000 | 59,100 | 30,000 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 13.50 | 7,407 | 99,995 | 52,593 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 9.99 | 5,025 | 50,200 | 49,975 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 9.96 | 5,001 | 49,810 | 14,999 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 15.24 | 6,561 | 99,990 | 33,439 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 19.73 | 5,068 | 99,992 | 34,932 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 7.05 | 7,503 | 52,896 | 32,497 | |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 8.86 | 13,080 | 115,889 | 112,089 | 99 K to 112.1 K (+13.21 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 5.91 | 10,000 | 59,100 | 99,009 | 89 K to 99 K (+11.23 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 13.50 | 7,407 | 99,995 | 89,009 | 81.6 K to 89 K (+9.08 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 9.99 | 5,025 | 50,200 | 81,602 | 76.6 K to 81.6 K (+6.56 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 9.96 | 5,001 | 49,810 | 76,577 | 71.6 K to 76.6 K (+6.99 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 15.24 | 6,561 | 99,990 | 71,576 | 65 K to 71.6 K (+10.09 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 19.73 | 5,068 | 99,992 | 65,015 | 59.9 K to 65 K (+8.45 %) |
| Jan 22 2014 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 7.05 | 7,503 | 52,896 | 59,947 | 52.4 K to 59.9 K (+14.31 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 17.84 | 2,346 | 41,853 | 18,059 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 11.31 | 6,250 | 70,688 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 8.86 | 9,336 | 82,717 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 5.91 | 4,000 | 23,640 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 13.50 | 6,000 | 81,000 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 9.99 | 6,952 | 69,450 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 13.97 | 2,500 | 34,925 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 15.24 | 4,452 | 67,848 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 8.71 | 6,949 | 60,526 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 19.73 | 9,000 | 177,570 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 7.05 | 12,000 | 84,600 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 17.84 | 2,346 | 41,853 | 110,768 | 108.4 K to 110.8 K (+2.16 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 11.31 | 6,250 | 70,688 | 108,422 | 102.2 K to 108.4 K (+6.12 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 8.86 | 9,336 | 82,717 | 102,172 | 92.8 K to 102.2 K (+10.06 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 5.91 | 4,000 | 23,640 | 92,836 | 88.8 K to 92.8 K (+4.50 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 13.50 | 6,000 | 81,000 | 88,836 | 82.8 K to 88.8 K (+7.24 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 9.99 | 6,952 | 69,450 | 82,836 | 75.9 K to 82.8 K (+9.16 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 13.97 | 2,500 | 34,925 | 75,884 | 73.4 K to 75.9 K (+3.41 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 15.24 | 4,452 | 67,848 | 73,384 | 68.9 K to 73.4 K (+6.46 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 8.71 | 6,949 | 60,526 | 68,932 | 62 K to 68.9 K (+11.21 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 19.73 | 9,000 | 177,570 | 61,983 | 53 K to 62 K (+16.99 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 7.05 | 12,000 | 84,600 | 52,983 | 41 K to 53 K (+29.28 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 8.86 | 11,286 | 99,994 | 33,714 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 5.91 | 12,690 | 74,998 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 13.50 | 7,407 | 99,995 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 9.99 | 3,778 | 37,742 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 9.96 | 6,251 | 62,260 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 15.24 | 6,561 | 99,990 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 19.73 | 5,068 | 99,992 | 54,932 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 7.05 | 7,503 | 52,896 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.14 | 18,582 | 58,347 | 0 | |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 8.86 | 11,286 | 99,994 | 482,281 | 471 K to 482.3 K (+2.40 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 5.91 | 12,690 | 74,998 | 470,995 | 458.3 K to 471 K (+2.77 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 13.50 | 7,407 | 99,995 | 458,305 | 450.9 K to 458.3 K (+1.64 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 9.99 | 3,778 | 37,742 | 450,898 | 447.1 K to 450.9 K (+0.84 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 9.96 | 6,251 | 62,260 | 447,120 | 440.9 K to 447.1 K (+1.42 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 15.24 | 6,561 | 99,990 | 440,869 | 434.3 K to 440.9 K (+1.51 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 19.73 | 5,068 | 99,992 | 434,308 | 429.2 K to 434.3 K (+1.18 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 7.05 | 7,503 | 52,896 | 429,240 | 421.7 K to 429.2 K (+1.78 %) |
| Jan 21 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.14 | 18,582 | 58,347 | 421,737 | 403.2 K to 421.7 K (+4.61 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 13.50 | 1,852 | 25,002 | 67,593 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 9.99 | 5,025 | 50,200 | 74,975 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 8.86 | 11,412 | 101,110 | 30,304 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 5.91 | 1,000 | 5,910 | 0 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Payment of Exercise | F | 49.80 | 558 | 27,788 | 153,332 | 153.9 K to 153.3 K (-0.36 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 13.50 | 1,852 | 25,002 | 153,890 | 152 K to 153.9 K (+1.22 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Payment of Exercise | F | 49.80 | 1,175 | 58,515 | 152,038 | 153.2 K to 152 K (-0.77 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 9.99 | 5,025 | 50,200 | 153,213 | 148.2 K to 153.2 K (+3.39 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Payment of Exercise | F | 49.80 | 2,419 | 120,466 | 148,188 | 150.6 K to 148.2 K (-1.61 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 8.86 | 11,412 | 101,110 | 150,607 | 139.2 K to 150.6 K (+8.20 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Payment of Exercise | F | 49.80 | 155 | 7,719 | 139,195 | 139.4 K to 139.2 K (-0.11 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 5.91 | 1,000 | 5,910 | 139,350 | 138.4 K to 139.4 K (+0.72 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 13.50 | 1,852 | 25,002 | 52,593 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 11.96 | 8,361 | 99,998 | 15,756 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 8.86 | 13,080 | 115,889 | 13,714 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 5.91 | 5,460 | 32,269 | 0 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Payment of Exercise | F | 49.80 | 558 | 27,788 | 87,026 | 87.6 K to 87 K (-0.64 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 13.50 | 1,852 | 25,002 | 87,584 | 85.7 K to 87.6 K (+2.16 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Payment of Exercise | F | 49.80 | 2,271 | 113,096 | 85,732 | 88 K to 85.7 K (-2.58 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 11.96 | 8,361 | 99,998 | 88,003 | 79.6 K to 88 K (+10.50 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Payment of Exercise | F | 49.80 | 2,773 | 138,095 | 79,642 | 82.4 K to 79.6 K (-3.36 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 8.86 | 13,080 | 115,889 | 82,415 | 69.3 K to 82.4 K (+18.86 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Payment of Exercise | F | 49.80 | 847 | 42,181 | 69,335 | 70.2 K to 69.3 K (-1.21 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 5.91 | 5,460 | 32,269 | 70,182 | 64.7 K to 70.2 K (+8.44 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 15.08 | 10,000 | 150,800 | 90,000 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 13.50 | 7,407 | 99,995 | 52,593 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 9.99 | 5,025 | 50,200 | 9,975 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 9.96 | 5,000 | 49,800 | 8,295 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 8.86 | 13,080 | 115,889 | 13,714 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 5.91 | 5,325 | 31,471 | 0 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Payment of Exercise | F | 49.80 | 3,317 | 165,187 | 70,877 | 74.2 K to 70.9 K (-4.47 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 15.08 | 10,000 | 150,800 | 74,194 | 64.2 K to 74.2 K (+15.58 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Payment of Exercise | F | 49.80 | 2,231 | 111,104 | 64,194 | 66.4 K to 64.2 K (-3.36 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 13.50 | 7,407 | 99,995 | 66,425 | 59 K to 66.4 K (+12.55 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Payment of Exercise | F | 49.80 | 1,175 | 58,515 | 59,018 | 60.2 K to 59 K (-1.95 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 9.99 | 5,025 | 50,200 | 60,193 | 55.2 K to 60.2 K (+9.11 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Payment of Exercise | F | 49.80 | 1,166 | 58,067 | 55,168 | 56.3 K to 55.2 K (-2.07 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 9.96 | 5,000 | 49,800 | 56,334 | 51.3 K to 56.3 K (+9.74 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Payment of Exercise | F | 49.80 | 2,773 | 138,095 | 51,334 | 54.1 K to 51.3 K (-5.13 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 8.86 | 13,080 | 115,889 | 54,107 | 41 K to 54.1 K (+31.88 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Payment of Exercise | F | 49.80 | 826 | 41,135 | 41,027 | 41.9 K to 41 K (-1.97 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 5.91 | 5,325 | 31,471 | 41,853 | 36.5 K to 41.9 K (+14.58 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 19.73 | 5,068 | 99,992 | 34,932 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 15.24 | 6,561 | 99,990 | 33,439 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 13.50 | 7,407 | 99,995 | 52,593 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 9.99 | 5,025 | 50,200 | 49,975 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 9.96 | 5,001 | 49,810 | 0 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 8.86 | 13,080 | 115,889 | 36,920 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 5.91 | 10,000 | 59,100 | 0 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 1.84 | 90,000 | 165,600 | 30,000 | |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 2,134 | 106,273 | 154,058 | 156.2 K to 154.1 K (-1.37 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 19.73 | 5,068 | 99,992 | 156,192 | 151.1 K to 156.2 K (+3.35 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 2,196 | 109,361 | 151,124 | 153.3 K to 151.1 K (-1.43 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 15.24 | 6,561 | 99,990 | 153,320 | 146.8 K to 153.3 K (+4.47 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 2,231 | 111,104 | 146,759 | 149 K to 146.8 K (-1.50 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 13.50 | 7,407 | 99,995 | 148,990 | 141.6 K to 149 K (+5.23 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 1,175 | 58,515 | 141,583 | 142.8 K to 141.6 K (-0.82 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 9.99 | 5,025 | 50,200 | 142,758 | 137.7 K to 142.8 K (+3.65 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 1,166 | 58,067 | 137,733 | 138.9 K to 137.7 K (-0.84 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 9.96 | 5,001 | 49,810 | 138,899 | 133.9 K to 138.9 K (+3.73 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 2,773 | 138,095 | 133,898 | 136.7 K to 133.9 K (-2.03 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 8.86 | 13,080 | 115,889 | 136,671 | 123.6 K to 136.7 K (+10.58 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 1,551 | 77,240 | 123,591 | 125.1 K to 123.6 K (-1.24 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 5.91 | 10,000 | 59,100 | 125,142 | 115.1 K to 125.1 K (+8.68 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Payment of Exercise | F | 49.80 | 6,914 | 344,317 | 115,142 | 122.1 K to 115.1 K (-5.66 %) |
| Jan 10 2014 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 1.84 | 90,000 | 165,600 | 122,056 | 32.1 K to 122.1 K (+280.76 %) |
| Jan 08 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | M | 3.42 | 10,000 | 34,200 | 0 | |
| Jan 08 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Payment of Exercise | F | 49.89 | 686 | 34,225 | 128,314 | 129 K to 128.3 K (-0.53 %) |
| Jan 08 2014 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Buy | M | 3.42 | 10,000 | 34,200 | 129,000 | 119 K to 129 K (+8.40 %) |
| Jan 07 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.55 | 40,309 | 143,097 | 0 | |
| Jan 07 2014 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.55 | 40,309 | 143,097 | 403,155 | 362.8 K to 403.2 K (+11.11 %) |
| Jan 03 2014 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Grant | A | 0.00 | 2,083 | 0 | 8,666 | 6.6 K to 8.7 K (+31.64 %) |